Sökning: "Beta-blocker therapy"

Visar resultat 1 - 5 av 10 avhandlingar innehållade orden Beta-blocker therapy.

  1. 1. The Association Between Beta-Blocker Therapy and Mortality in Hip Fracture Patients

    Författare :Ahmad Mohammad Ismail; Shahin Mohseni; Rebecka Ahl; Per Wretenberg; Tomas Borg; Björn Rosengren; Örebro universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Trauma; Hip Fracture; Beta-Blocker; Hyperadrenergic State; Stress; Mortality;

    Sammanfattning : Hip fractures have been a major concern within the healthcare systems for many years. National efforts have been done to improve the overall outcomes during the last decades. Despite this, the mortality rates one year after hip fracture surgery are as high as 27% and have remained high the past 15 years. LÄS MER

  2. 2. Factors influencing outcome in patients with obstructive hypertrophic cardiomyopathy - Effects of pharmacotherapy, pacing and surgical myectomy

    Författare :Davood Javidgonbadi; Göteborgs universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Hypertrophic obstructive cardiomyopathy; myectomy; pacing; beta-blocker; survival; sex; re-intervention rate;

    Sammanfattning : Background: Most studies on risk factors for disease-related mortality in hypertrophic cardiomyopathy (HCM) have emanated from specialized tertiary centres which are subject to possible referral bias. About one quarter of HCM-patients have outflow obstruction in the left ventricle, hypertrophic obstructive cardiomyopathy (HOCM). LÄS MER

  3. 3. Mortality in Oxygen-Dependent Chronic Obstructive Pulmonary Disease and Possibilities for Pharmacological Interventions

    Författare :Magnus Ekström; allergologi och palliativ medicin Lungmedicin; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; COPD; mortality; survival; comorbidity; cardiovascular disease; cardiovascular drugs; angiotensin-converting enzyme inhibitor; angiotensin receptor blocker; beta blocker; statin; aspirin; antiplatelet drug; gender; sex; oxygen-dependent; LTOT; trends; excess mortality; SMR; hypoxemia; hypoxia; hypoxaemic;

    Sammanfattning : Background Chronic obstructive pulmonary disease (COPD) is a major and rising cause of mortality worldwide, especially in women. Patients with chronic hypoxia owing to COPD are treated with long-term oxygen therapy (LTOT) but have high morbidity and mortality. LÄS MER

  4. 4. The Association Between Beta-Blockade and Clinical Outcomes in the Context of Surgical and Traumatic Stress

    Författare :Rebecka Ahl; Shahin Mohseni; Louis Riddez; Göran Wallin; Olle Ljungqvist; Jonathan Tilsed; Örebro universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Beta-blocker therapy; adrenergic hyperactivity; physiological stress; trauma; depression; colorectal cancer; complications; mortality;

    Sammanfattning : Traumatic injury and major abdominal surgery are areas in general surgery associated with high rates of morbidity and mortality. The overall colorectal cancer surgery mortality rate is around 4%, with that for emergency surgery more than twice as high as for planned. Surgical morbidity varies between 25% and 45%. LÄS MER

  5. 5. Screening for Hypertrophic Cardiomyopathy in Asymptomatic Children and Adolescents. Psychosocial consequences and impact on quality of life and physical activity

    Författare :Ewa-Lena Bratt; Göteborgs universitet; []
    Nyckelord :Adolescents; Beta-blocker therapy; children; exercise performance; family screening; hypertrophic cardiomyopathy; parents experiences; psychosocial consequences; quality of life; transition;

    Sammanfattning : The aim of this thesis was to describe the consequences of being diagnosed with hypertrophic cardiomyopathy (HCM) while being asymptomatic, taking into consideration psychosocial effects and medical aspects of diagnosis and treatment. Methods: Quality of life (QoL) was measured according to Lindström before the diagnosis, and after two years, comparing with healthy controls. LÄS MER